Lord, Abbett & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Lord, Abbett & Co's CELG Position: Q4 2017 in Review
Lord, Abbett & Co sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 630,866 shares — an estimated $92M sold.
Lord, Abbett & Co first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $194M in Q2 2014. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- Lord, Abbett & Co reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
- Lord, Abbett & Co sold 630,866 Celgene Corp shares in Q4 2017, an estimated $92M.
- Lord, Abbett & Co first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
- Lord, Abbett & Co's Celgene Corp position peaked at $194M in Q2 2014.
- 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.
Based on Lord, Abbett & Co's 13F filing for Q4 2017, filed 14 Feb 2018.